Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis.

Lu C, Diehl SA, Noubade R, Ledoux J, Nelson MT, Spach K, Zachary JF, Blankenhorn EP, Teuscher C.

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18967-72. doi: 10.1073/pnas.1008816107. Epub 2010 Oct 18.

2.

von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.

Noubade R, del Rio R, McElvany B, Zachary JF, Millward JM, Wagner DD, Offner H, Blankenhorn EP, Teuscher C.

Am J Pathol. 2008 Sep;173(3):892-900. doi: 10.2353/ajpath.2008.080001. Epub 2008 Aug 7.

3.

H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis.

Saligrama N, Noubade R, Case LK, Poynter ME, Teuscher C.

Cell Immunol. 2012 Jul-Aug;278(1-2):27-34. doi: 10.1016/j.cellimm.2012.06.012. Epub 2012 Jul 14.

4.

Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.

Saligrama N, Case LK, del Rio R, Noubade R, Teuscher C.

J Immunol. 2013 Jul 15;191(2):614-22. doi: 10.4049/jimmunol.1203137. Epub 2013 Jun 14.

5.

Identification of Bphs, an autoimmune disease locus, as histamine receptor H1.

Ma RZ, Gao J, Meeker ND, Fillmore PD, Tung KS, Watanabe T, Zachary JF, Offner H, Blankenhorn EP, Teuscher C.

Science. 2002 Jul 26;297(5581):620-3.

6.

Endothelial Von Willebrand factor promotes blood-brain barrier flexibility and provides protection from hypoxia and seizures in mice.

Suidan GL, Brill A, De Meyer SF, Voorhees JR, Cifuni SM, Cabral JE, Wagner DD.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2112-20. doi: 10.1161/ATVBAHA.113.301362. Epub 2013 Jul 3.

7.

Analysis of the role of Bphs/Hrh1 in the genetic control of responsiveness to pertussis toxin.

Gao JF, Call SB, Fillmore PD, Watanabe T, Meeker ND, Teuscher C.

Infect Immun. 2003 Mar;71(3):1281-7.

8.

Combinatorial roles for histamine H1-H2 and H3-H4 receptors in autoimmune inflammatory disease of the central nervous system.

Saligrama N, Noubade R, Case LK, del Rio R, Teuscher C.

Eur J Immunol. 2012 Jun;42(6):1536-46. doi: 10.1002/eji.201141859.

9.

Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.

Göbel K, Pankratz S, Schneider-Hohendorf T, Bittner S, Schuhmann MK, Langer HF, Stoll G, Wiendl H, Kleinschnitz C, Meuth SG.

J Autoimmun. 2011 Mar;36(2):106-14. doi: 10.1016/j.jaut.2010.11.004. Epub 2011 Jan 8.

PMID:
21216565
10.

ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.

Zheng M, Wei J, Tang Y, Yang C, Wei Y, Yin X, Liu Q.

J Mol Neurosci. 2014;54(2):282-90. doi: 10.1007/s12031-014-0291-x. Epub 2014 May 1.

PMID:
24788224
11.

Histamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.

Krementsov DN, Wall EH, Martin RA, Subramanian M, Noubade R, Del Rio R, Mawe GM, Bond JP, Poynter ME, Blankenhorn EP, Teuscher C.

PLoS One. 2013 Jul 22;8(7):e62743. doi: 10.1371/journal.pone.0062743. Print 2013.

12.

Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.

Cruz-Orengo L, Daniels BP, Dorsey D, Basak SA, Grajales-Reyes JG, McCandless EE, Piccio L, Schmidt RE, Cross AH, Crosby SD, Klein RS.

J Clin Invest. 2014 Jun;124(6):2571-84. doi: 10.1172/JCI73408. Epub 2014 May 8.

13.

Autoimmune disease-associated histamine receptor H1 alleles exhibit differential protein trafficking and cell surface expression.

Noubade R, Saligrama N, Spach K, Del Rio R, Blankenhorn EP, Kantidakis T, Milligan G, Rincon M, Teuscher C.

J Immunol. 2008 Jun 1;180(11):7471-9. Erratum in: J Immunol. 2008 Oct 1;181(7):5174.

14.

DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.

Minten C, Alt C, Gentner M, Frei E, Deutsch U, Lyck R, Schaeren-Wiemers N, Rot A, Engelhardt B.

Brain. 2014 May;137(Pt 5):1454-69. doi: 10.1093/brain/awu045. Epub 2014 Mar 12.

15.

Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.

Chapouly C, Tadesse Argaw A, Horng S, Castro K, Zhang J, Asp L, Loo H, Laitman BM, Mariani JN, Straus Farber R, Zaslavsky E, Nudelman G, Raine CS, John GR.

Brain. 2015 Jun;138(Pt 6):1548-67. doi: 10.1093/brain/awv077. Epub 2015 Mar 23.

16.

Saturable leptin transport across the BBB persists in EAE mice.

Hsuchou H, Mishra PK, Kastin AJ, Wu X, Wang Y, Ouyang S, Pan W.

J Mol Neurosci. 2013 Oct;51(2):364-70. doi: 10.1007/s12031-013-9993-8. Epub 2013 Mar 16.

17.

Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.

Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, Engelhardt B, Madri JA.

J Clin Invest. 2002 Feb;109(3):383-92.

18.

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.

Liu L, Huang D, Matsui M, He TT, Hu T, Demartino J, Lu B, Gerard C, Ransohoff RM.

J Immunol. 2006 Apr 1;176(7):4399-409.

19.

Netrin 1 regulates blood-brain barrier function and neuroinflammation.

Podjaski C, Alvarez JI, Bourbonniere L, Larouche S, Terouz S, Bin JM, Lécuyer MA, Saint-Laurent O, Larochelle C, Darlington PJ, Arbour N, Antel JP, Kennedy TE, Prat A.

Brain. 2015 Jun;138(Pt 6):1598-612. doi: 10.1093/brain/awv092. Epub 2015 Apr 22.

20.

Supplemental Content

Support Center